| Maxwell Krakowiak |
Maxwell Krakowiak is Chief Financial Officer & Senior Vice President at PerkinElmer, Inc. (United States).
In his past career he was Executive Audit Manager at General Electric Co.
He received an undergraduate degree from Fordham University. |
| Andrew Okun |
Currently, Andrew Okun occupies the position of Chief Accounting Officer, Treasurer & VP at PerkinElmer, Inc. (United States).
He previously occupied the position of Site Controller-Commercial Avionics Business at Honeywell International, Inc. and Senior Tax Associate at Coopers & Lybrand LLP.
Andrew Okun received an undergraduate degree from the University of California, Santa Barbara and an MBA from the University of Virginia. |
| Prahlad Ramadhar Singh |
Prahlad Ramadhar Singh is on the board of Amphenol Corp. and Analytical Life Science & Diagnostics Association and President, Chief Executive Officer & Director at PerkinElmer, Inc. (United States).
He previously occupied the position of Chairman at PerkinElmer Oy, Member-President's Council at The General Hospital Corp. and General Manager-Womens Health Business at GE Healthcare, Inc.
He received an MBA from Northeastern University and a doctorate from the University of Missouri. |
| Michelle McMurry-Heath |
Michelle McMurry-Heath is on the board of PerkinElmer, Inc. (United States) and 4 other companies.
In her past career she held the position of President & Chief Executive Officer for Biotechnology Innovation Organization and Founding Director-Society Policy Program at The Aspen Institute, Inc.
She received a doctorate from Duke University and an undergraduate degree from Harvard University. |
| Michel Pericles Vounatsos |
Presently, Michel Pericles Vounatsos occupies the position of Chairman-Supervisory Board at L’Institut de RYthmologie et Modélisation Cardiaque, Chief Executive Officer & Director at Biogen Idec, Inc. (North Carolina) and Chief Executive Officer & Member-Supervisory Board at Biogen GmbH. Mr. Vounatsos is also on the board of PerkinElmer, Inc. (United States), PerkinElmer BV, Zai Lab Ltd. and n-Lorem Foundation.
In the past he occupied the position of Chief Executive Officer & Director at Biogen, Inc. and President-Primary Care & Customer Centricity at Merck & Co., Inc.
Mr. Vounatsos received an MBA from École des Hautes Études Commerciales de Paris. |
| Pascale Witz |
Pascale Witz is a French businessperson who founded PWH Advisors and who has been the head of 5 different companies. Presently, Ms. Witz is Chairman for RTI Surgical, Inc., President & Chief Executive Officer for PWH Advisors and Senior Advisor at Arsenal Capital Management LP. Pascale Witz is also on the board of 15 other companies.
She previously occupied the position of Executive VP-Diabetes & Cardiovascular at Sanofi, President & Chief Executive Officer at GE Healthcare Medical Diagnostics, President & CEO-Medical Diagnostics at GE Healthcare Ltd. (United Kingdom), President & GM-Interventional Radiology at GE Healthcare IVD Technologies and Marketing Manager at Becton Dickinson France SAS.
She received a graduate degree from Institut National des Sciences Appliquées de Lyon and an MBA from INSEAD. |
| Samuel Ross Chapin |
Samuel Ross Chapin is on the board of CIRCOR International, Inc. and 5 other companies.
In his past career he occupied the position of President for Merrill Lynch Canada, Inc., Vice Chairman of Merrill Lynch & Co., Inc., Principal at The Chase Manhattan Bank NA and Executive Vice Chairman at Merrill Lynch, Pierce, Fenner & Smith, Inc.
Mr. Chapin received an undergraduate degree from Lafayette College and an MBA from The Wharton School of the University of Pennsylvania. |
| Peter Barrett |
Founder of Celera Corp., Peter Barrett is a businessperson who has been at the head of 12 different companies and presently holds the position of Chairman for Synlogic, Inc., Chairman of Synlogic Operating Co., Inc. (a subsidiary of Synlogic, Inc.), Partner at Atlas Ventures Advisors, Inc., Partner at Atlas Venture Life Science Advisors LLC and Chairman for Cadent Therapeutics, Inc. He is also President at Autism Consortium, Senior Fellow at Harvard Business School and Partner at Life Sciences Group, Inc. and on the board of 6 other companies.
Dr. Barrett previously was Chairman at Ivrea Pharmaceuticals, Inc., Chairman for Analytical Life Science & Diagnostics Association, Chairman & President for Raze Therapeutics, Inc., Chairman for Momenta Pharmaceuticals, Inc., Chairman of Zafgen, Inc., Director at Harbour Antibodies BV, VP-Corporate Planning & Business Development at Applera Corp., Chief Business Officer & Executive Vice President at Celera Corp., Vice President-Planning & Business Development at PE Corp. (New York) and Member-Research Council at The Children's Hospital Corp.
He received a doctorate from Northeastern University and an undergraduate degree from the University of Massachusetts Lowell. |
| Sylvie Louise Grégoire |
Founder of EIP Pharma, Inc., Sylvie Louise Grégoire is a Canadian businessperson who has been at the head of 6 different companies and currently is Executive Chairman at this company and Chairman at Corvidia Therapeutics, Inc. She is also on the board of 5 other companies.
In her past career she occupied the position of Chairman of Metriopharm AG, Executive Vice President-Business Development at Biogen, Inc. and Executive Vice President-Technical Operations at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Executive Chairman for IDM Pharma, Inc., President, CEO & Executive Director at GlycoFi, Inc., President of Shire Human Genetic Therapies, Inc. and President-Human Genetic Therapies Division at Shire Plc.
Sylvie Louise Grégoire received an undergraduate degree from Université Laval, a doctorate from State University of New York at Buffalo and an undergraduate degree from Séminaire de Sherbrooke. |
| Franklin R. Witney |
Franklin R. Witney is a businessperson who has been at the helm of 11 different companies. Dr. Witney holds the position of Chairman at Telesis Bio, Inc., Chairman for Gyros AB, Chairman for Gyros Protein Technologies AB and Chairman of Canopy Biosciences LLC. Dr. Witney is also on the board of 10 other companies.
He previously held the position of Operations Manager-Life Science Group at Bio-Rad Laboratories, Inc., President, Chief Executive Officer & Director at Dionex Corp., President, Chief Executive Officer & Director at Affymetrix, Inc., President & Chief Executive Officer for Panomics LLC, Chief Executive Officer & Director at eBioscience, Inc., President & Chief Operating Officer for Packard BioScience Co., President & Chief Executive Officer at GenoSpectra, Inc., President for Drug Discovery Facility, Chief Commercial Officer & Executive VP for Affymetrix, Inc. and President-Drug Discovery Tools at PerkinElmer Life Sciences, Inc.
He received a doctorate from Indiana University and an undergraduate degree from the University of Illinois. |
